Everyone hopes and wishes for that last-minute cancer breakthrough that will save doomed patients. It almost never actually happens. With Gleevec, it did. The once-a-day pill turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. Now data shows it’s helped 83 percent of patients live 10 years or longer. And some may be able to stop taking the pills altogether, even though they are not cured.
http://www.nbcnews.com/health/cancer/cancer-pill-gleevec-keeps-patients-alive-well-decade-n730951
